Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9843084rdf:typepubmed:Citationlld:pubmed
pubmed-article:9843084lifeskim:mentionsumls-concept:C0015576lld:lifeskim
pubmed-article:9843084lifeskim:mentionsumls-concept:C1556094lld:lifeskim
pubmed-article:9843084lifeskim:mentionsumls-concept:C0439849lld:lifeskim
pubmed-article:9843084lifeskim:mentionsumls-concept:C0206245lld:lifeskim
pubmed-article:9843084lifeskim:mentionsumls-concept:C0026882lld:lifeskim
pubmed-article:9843084lifeskim:mentionsumls-concept:C0023401lld:lifeskim
pubmed-article:9843084lifeskim:mentionsumls-concept:C0032923lld:lifeskim
pubmed-article:9843084lifeskim:mentionsumls-concept:C0445223lld:lifeskim
pubmed-article:9843084lifeskim:mentionsumls-concept:C1552599lld:lifeskim
pubmed-article:9843084lifeskim:mentionsumls-concept:C1704787lld:lifeskim
pubmed-article:9843084pubmed:issue12lld:pubmed
pubmed-article:9843084pubmed:dateCreated1998-12-23lld:pubmed
pubmed-article:9843084pubmed:abstractTextA rare variant transthyretin that has a leucine-for-valine substitution at position 30 was reported in a sporadic case of type 1 familial amyloid polyneuropathy (FAP). We found the same substitution in members of a Japanese family with FAP. Three individuals in this family had a guanine-to-cytosine mutation at the first base of codon 30 in exon 2. This family shows a direct link between a valine-to-leucine substitution at position 30 and type 1 FAP.lld:pubmed
pubmed-article:9843084pubmed:languageenglld:pubmed
pubmed-article:9843084pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9843084pubmed:citationSubsetIMlld:pubmed
pubmed-article:9843084pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9843084pubmed:statusMEDLINElld:pubmed
pubmed-article:9843084pubmed:monthDeclld:pubmed
pubmed-article:9843084pubmed:issn0148-639Xlld:pubmed
pubmed-article:9843084pubmed:authorpubmed-author:SaitoKKlld:pubmed
pubmed-article:9843084pubmed:authorpubmed-author:NaganoSSlld:pubmed
pubmed-article:9843084pubmed:authorpubmed-author:TohgiHHlld:pubmed
pubmed-article:9843084pubmed:authorpubmed-author:MiharaMMlld:pubmed
pubmed-article:9843084pubmed:authorpubmed-author:YamagataMMlld:pubmed
pubmed-article:9843084pubmed:authorpubmed-author:UtsugisawaKKlld:pubmed
pubmed-article:9843084pubmed:issnTypePrintlld:pubmed
pubmed-article:9843084pubmed:volume21lld:pubmed
pubmed-article:9843084pubmed:ownerNLMlld:pubmed
pubmed-article:9843084pubmed:authorsCompleteYlld:pubmed
pubmed-article:9843084pubmed:pagination1783-5lld:pubmed
pubmed-article:9843084pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:9843084pubmed:meshHeadingpubmed-meshheading:9843084-...lld:pubmed
pubmed-article:9843084pubmed:meshHeadingpubmed-meshheading:9843084-...lld:pubmed
pubmed-article:9843084pubmed:meshHeadingpubmed-meshheading:9843084-...lld:pubmed
pubmed-article:9843084pubmed:meshHeadingpubmed-meshheading:9843084-...lld:pubmed
pubmed-article:9843084pubmed:meshHeadingpubmed-meshheading:9843084-...lld:pubmed
pubmed-article:9843084pubmed:meshHeadingpubmed-meshheading:9843084-...lld:pubmed
pubmed-article:9843084pubmed:meshHeadingpubmed-meshheading:9843084-...lld:pubmed
pubmed-article:9843084pubmed:meshHeadingpubmed-meshheading:9843084-...lld:pubmed
pubmed-article:9843084pubmed:meshHeadingpubmed-meshheading:9843084-...lld:pubmed
pubmed-article:9843084pubmed:meshHeadingpubmed-meshheading:9843084-...lld:pubmed
pubmed-article:9843084pubmed:meshHeadingpubmed-meshheading:9843084-...lld:pubmed
pubmed-article:9843084pubmed:year1998lld:pubmed
pubmed-article:9843084pubmed:articleTitleFamilial amyloid polyneuropathy related to transthyretin mutation Val30 to Leu in a Japanese family.lld:pubmed
pubmed-article:9843084pubmed:affiliationDepartment of Neurology, Iwate Medical University, Morioka, Japan.lld:pubmed
pubmed-article:9843084pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9843084pubmed:publicationTypeCase Reportslld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9843084lld:pubmed